The MIND Institute at UC Davis is enrolling participants in clinical trials for an autism treatment developed by Curemark LLC, a drug research and development company in Rye, N.Y.

http://www.bizjournals.com/sacramento/stories/2010/05/03/daily34.html?s=industry&i=health_care